Zhaolin Xu

Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.

Gillian Bethune, Drew Bethune, Neale D. Ridgway et al. · PubMed · 2010 · 389 citations

Medicine, Cancer Biology, Oncology +17

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study

Martin C. Tammemägi, Heidi Schmidt, Simon Martel et al. · The Lancet Oncology · 2017 · 219 citations

Medicine, Oncology, Preventive Medicine +16

The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency

Sonya Cressman, Stuart Peacock, Martin C. Tammemägi et al. · Journal of Thoracic Oncology · 2017 · 141 citations · Full text

Medicine, Oncology, Preventive Medicine +14

Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer

Jean‐Claude Cutz, Kenneth J. Craddock, Emina Torlakovic et al. · Journal of Thoracic Oncology · 2014 · 79 citations

Medicine, Oncology, Pathology +13

Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma

Katey S.S. Enfield, Erin A. Marshall, Kevin W. Ng et al. · Nature Communications · 2019 · 71 citations · Full text

Medicine, Genetics, Oncology +17